Evidence map›Paper›PMID 40293592›Full record

ArticleBulletin of experimental biology and medicine2025

Antimicrobial Effect of Lactobacillus Supernatant on Polyresistant Bacteria of the ESKAPE Group.

T A Danilova, A A Adzhieva, G A Danilina, A G Minko, O A Dmitrenko, V G Zhukhovitsky

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

T A DanilovaN. F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia. dansen@inbox.ru.
A A AdzhievaN. F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia.
G A DanilinaN. F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia.
A G MinkoN. F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia.
O A DmitrenkoN. F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia.
V G ZhukhovitskyN. F. Gamaleya Federal Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactobacillus supernatants exhibit pronounced antimicrobial activity against a number of bacteria of bacteria of the ESKAPE group. The antimicrobial activity of the supernatant was evaluated using the broth microdilution assay on polystyrene plates. The highest level of inhibition (more than 10 times compared with the control) was observed against gram-positive S. aureus. Among gram-negative bacteria, the maximum level of inhibition (9.4 times compared with the control) was noted for P. aeruginosa and slightly lower in A. baumannii and K. pneumoniae. The supernatants also inhibited biofilm formation by both gram-positive and gram-negative bacteria.

Indexed as

Anti-Bacterial AgentsLactobacillusAcinetobacter baumanniiBiofilmsGram-Negative BacteriaGram-Positive BacteriaKlebsiella pneumoniaeMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial AgentsbiofilmESKAPE bacterialactobacillussupernatant

Identifiers

PMID40293592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.